October 15, 2020 SITC 2020 – embargo snafu triggers the first movers The SITC breaks its own embargo, and the ensuing chaos sees Replimune, Iovance and Incyte move.
October 09, 2019 SITC 2019 preview – Nextcure’s time to shine The biotech calendar’s next key conference gets under way in a month, and a presentation by Nextcure will be a focus for some investors.
January 08, 2018 Asia wins 2017’s mid-cap race A cooling of the M&A climate allows Asia-based groups to come to the fore.
